Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
January 05 2021 - 8:00AM
Business Wire
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a
leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing,
announced that Dr. James A. Hayward, president and CEO, will
participate in a fireside chat at the virtual H.C. Wainwright
BIOCONNECT 2021 Conference to be held January 11-14, 2021. The
fireside chat will be hosted by Yi Chen, Managing Director, H.C.
Wainwright Equity Research, and Applied DNA covering analyst.
The fireside chat will be available for on-demand listening
beginning on Monday, January 11, 2021, at 6:00 a.m. Eastern
Standard Time on the IR Calendar section of the Applied DNA website
at www.adnas.com. An archived replay of the fireside chat will be
available on the Company’s website for 90 days.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping, and pre-clinical nucleic acid-based
therapeutic drug candidates.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under ticker
symbol ‘APDN’, and its publicly traded warrants are listed on OTC
under ticker symbol ‘APPDW’.
Applied DNA is a member of the Russell Microcap® Index.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005196/en/
Investor contact: Sanjay M. Hurry, Applied DNA Sciences,
917-733-5573, sanjay.hurry@adnas.com Web: www.adnas.com
Twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024